Fractionated Therapy of HER2-Expressing Breast and Ovarian Cancer Xenografts in Mice with Targeted Alpha Emitting 227Th-DOTA-p-benzyl-trastuzumabHelèn Heyerdahl, Jostein Dahle, Nasir Abbas et al.|PLoS ONE|2012Cited by 63
Comparing High LET <sup>227</sup>Th- and Low LET <sup>177</sup>Lu-trastuzumab in Mice with HER-2 Positive SKBR-3 XenograftsNasir Abbas, Jostein Dahle, Helèn Heyerdahl et al.|Current Radiopharmaceuticals|2013Cited by 15
Modifications in Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameters After α-Particle-Emitting 227Th-trastuzumab Therapy of HER2-Expressing Ovarian Cancer XenograftsHelèn Heyerdahl, Jostein Dahle, Kathrine Røe et al.|International Journal of Radiation Oncology*Biology*Physics|2013Cited by 9